Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Welcome to VJHemOnc - an independent, open-access video journal delivering the latest news, insights and education in hematology.

Explore expert interviews from international congresses, dive into disease-specific content, and stay informed on practice-changing advances.
WATCH (3)
Evaluating the role of SCT vs CAR-T in LBCL

Explore this engaging discussion with Paolo Strati, Evandro Bezerra, and Andrew Jallouk, who discuss the role of autoSCT vs CAR-T in LBCL
cll. hp tile
Updated recommendations & novel therapies for Richter's

Explore our feature article covering key updates in Richter's transformation featuring experts Adam Kittai and Matthew Davids
WATCH (4)
Advances in MCL treatment: TRIANGLE, BTKis, & more

Explore this discussion featuring experts Martin Dreyling and Georg Hess who discuss advances in MCL treatment
fl hp tile
Shaping the future of R/R FL: bispecific antibodies

Explore our feature article which covers the value of bispecific antibodies in R/R FL
Currently Trending
Watch Martin Kaiser discuss Beyond genetics: how RNA profiling enhances risk detection in multiple myeloma 2:26
Beyond genetics: how RNA profiling enhances risk detection in multiple myeloma
Martin Kaiser • 24 Oct 2025
Watch Gilles Salles et al. discuss Novel therapies and ongoing trials in NHL: advances in antibody-based combinations 15:43
Novel therapies and ongoing trials in NHL: advances in antibody-based combinations
Gilles Salles et al. • 27 Sep 2025
Watch Asfand Yar Cheema discuss GLP-1 agonists and clinical outcomes in polycythemia vera & MDS 10:06
GLP-1 agonists and clinical outcomes in polycythemia vera & MDS
Asfand Yar Cheema • 5 Sep 2025
Watch Gail Roboz discuss One big question with Gail Roboz: what AML advance could transform frontline care in three years? 2:13
One big question with Gail Roboz: what AML advance could transform frontline care in three years?
Gail Roboz • 26 Sep 2025
CLL Wide Banner Nov25 (1) copy MM Wide Banner CAR-T_focus_wide-banner copy Lymphoma Wide Banner (3) MPN Wide Banner MDS Wide Banner Amyloidosis Wide Banner copy vj-RD-hub-wide-banner Sickle Cell Disease Wide Banner Thalassemia Wide Banner AML-Wide-Banner-2 copy
View Latest Videos by Disease
Watch the latest videos from the Multiple Myeloma Channel
Multiple Myeloma
Watch the latest videos from the Lymphoma Channel
Lymphoma
Watch the latest videos from the Chronic Lymphocytic Leukemia Channel
Chronic Lymphocytic Leukemia
Watch the latest videos from the Acute Myeloid Leukemia Channel
Acute Myeloid Leukemia
Watch the latest videos from the Myelodysplastic Syndromes Channel
Myelodysplastic Syndromes
Watch the latest videos from the Myeloproliferative Neoplasms Channel
Myeloproliferative Neoplasms
Watch the latest videos from the Acute Lymphoblastic Leukemia Channel
Acute Lymphoblastic Leukemia
Watch the latest videos from the Amyloidosis Channel
Amyloidosis
Watch the latest videos from the Sickle Cell Disease Channel
Sickle Cell Disease
Watch the latest videos from the Hemophilia Channel
Hemophilia
Watch the latest videos from the Thalassemia Channel
Thalassemia
Watch the latest videos from the Blastic Plasmacytoid Dendritic Cell Neoplasm Channel
Blastic Plasmacytoid Dendritic Cell Neoplasm
View all diseases
View more content
Trials
Medicines
Conferences
Features
The content of VJHemOnc is intended for healthcare professionals